RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma
Open Access
- 8 December 2006
- Vol. 107 (12), 2752-2759
- https://doi.org/10.1002/cncr.22325
Abstract
BACKGROUND. Allelotype studies have suggested that chromosome 1p is frequently lost in thyroid cancers, thus suggesting that there is an important tumor suppressor at this location. RIZ1 (PRDM2), located on 1p36, is a recently described tumor suppressor gene and is a member of the protein methyltransferase superfamily. RIZ1 expression is lost in a variety of tumors, primarily by means of epigenetic mechanisms that involve promoter hypermethylation. METHODS. RIZ1 expression was examined in a panel of thyroid tumor cell lines and primary thyroid tissues (14 normal, 19 benign, and 31 cancerous) by using real-time polymerase chain reaction (PCR). Methylation status of the RIZ1 promoter was studied using bisulfite sequencing and methylation-specific PCR. RESULTS. The authors demonstrated that RIZ1 expression is lost in thyroid tumor cell lines and is also significantly reduced in thyroid carcinomas, when compared with normal thyroid tissues (P < .0001) and benign tumors (P = .0003). The current study results also showed that loss of RIZ1 is mediated by aberrant cytosine methylation of the RIZ1 promoter. One hundred percent of carcinomas were methylated, compared with 33% of normal thyroid tissues (P = .001). RIZ1 mRNA expression was significantly higher (P = .02) in unmethylated (1.22 ± 1.2, mean ± standard deviation [SD]), compared with methylated tissues (0.37 ± 0.42, mean ± SD). Last, treatment with a DNA methyltransferase inhibitor led to reactivation of RIZ1 expression in cell lines that had negligible RIZ1 expression at baseline. CONCLUSIONS. The current study suggested an important role for RIZ1 expression in thyroid tumorigenesis and identified a potential novel therapeutic target for tumors unresponsive to other therapies. Cancer 2006. © 2006 American Cancer Society.Keywords
This publication has 26 references indexed in Scilit:
- The epigenetic progenitor origin of human cancerNature Reviews Genetics, 2006
- Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression riskOncogene, 2005
- Mutated E-Cadherin: Genomic and Functional Characterization in Thyroid Cells from the KAT FamilyThyroid®, 2004
- Aberrant Promoter Hypermethylation of Multiple Genes in Gallbladder Carcinoma and Chronic CholecystitisClinical Cancer Research, 2004
- Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinomaInternational Journal of Cancer, 2004
- Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomasSurgery, 2003
- Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein–methyltransferase superfamilyGenes & Development, 2001
- The retinoblastoma protein-interacting zinc finger gene RIZ in 1p36-linked cancersFrontiers in Bioscience-Landmark, 1999
- An Immunohistochemical Study of RB Tumor Suppressor Gene Protein and bcl-2 Gene Protein in Carcinomas of the Thyroid Gland.Nippon Jibiinkoka Gakkai Kaiho, 1998
- Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid glandThe Journal of Pathology, 1994